Anthony Defino

KIAWAH ISLAND, S.C. — In patients with proliferative diabetic retinopathy , ranibizumab delivered with the Port Delivery System yielded a reduced

KIAWAH ISLAND, S.C. — Despite using a lower energy setting, direct selective laser trabeculoplasty yielded comparable outcomes to traditional SLT among patients with primary open-angle glaucoma and ocular hypertension.

WASHINGTON — A modular shape-changing IOL helped patients with presbyopia achieve good vision at different distances, according to a study presented at the American Society of Cataract and Refractive Surgery meeting.

MIAMI — Combining minimally invasive glaucoma surgery with pharmaceutical drug delivery is an option to lower IOP in patients who are pseudophakic, according to a speaker.

Key takeaways: Mahsaw Mansoor, MD, explains her decision to pursue a second fellowship. Work-life balance is important, but a “season of intensity” can propel professional growth.

WASHINGTON — Cyclodialysis performed with modern ab interno approaches should not be discounted as a treatment option for glaucoma, according to a speaker.

LAS VEGAS — Ocula360, an AI-based tool for diabetic retinopathy lesion detection, showed efficacy in detecting DR across multiple levels of severity, according to a speaker at Clinical Trials at the Summit. While several automated DR assessment tools have been FDA approved, there are limitations in screening for disease severity, SriniVas R. Sadda, MD, of Doheny Eye Institute, said.

DENVER — A real-world analysis showed increased rates of undertreatment and attrition with anti-VEGF injections in patients with wet age-related macular degeneration over time, resulting in worse visual outcomes. According to a poster presented at the Association for Research in Vision and Ophthalmology meeting, the study aimed to address the knowledge gaps on the long-term impact of

DENVER —The largest global, prospective, noninterventional study of faricimab demonstrated “robust, rapid” anatomical improvements in patients with diabetic macular edema , according to a speaker.

DENVER — In a phase 1b trial, subretinal delivery of a human stem cell-derived retinal pigment epithelium yielded visual improvements in patients with advanced geographic atrophy, according to a speaker.“This study looked at subretinal stem cell implants through a pars plana vitrectomy surgery, where we created a bleb directly over the site of geographic atrophy,” Vivienne S.